| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |